Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. Over the past few years, ...

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, ...

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business ...

We came across a bullish thesis on Medtronic plc (MDT) on Investing Intel’s Substack. In this article, we will summarize the ...

Verizon and Medtronic offer high yields, growth potential, and undervalued prices. Perfect picks for conservative, long-term ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 ...

Intuitive Surgical ISRG and MedtronicMDT are two powerhouses in the rapidly evolving field of robotic-assisted surgery. As ...

The bioelectric medicine market is growing at a CAGR of approximately 6-8% during the forecast period. The primary factors ...